Cargando…
FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
BACKGROUND: FDG PET-CT is generally not suitable for diagnosing prostate cancer because of low glycolysis of the tumor cells. Neuroendocrine differentiation of the prostate cancer is often associated with early visceral metastasis and dismal prognosis, which is resulted from changed metabolic and re...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440384/ https://www.ncbi.nlm.nih.gov/pubmed/18565231 http://dx.doi.org/10.1186/1477-7819-6-64 |